Repligen (RGEN) investor relations material

Key strategic themes

• Innovation and diversification drive growth, with a broad product portfolio and a focus on launching new solutions and technologies across bioprocessing, including fluid management, filtration, chromatography, analytics, proteins, and ligands.

• Strategic expansion in Asia, especially China, is a priority, supported by new leadership, OEM deals, and a strategy to capture rapid market growth.

• Transformation Office established to accelerate top-line growth and margin improvement, targeting 30% EBITDA margin by 2030 and delivering at least one point of annualized margin benefit by end of 2027.

• Digitization and process analytical technologies are central, with plans to integrate digital twins and AI for process optimization.

• M&A remains a top capital allocation priority, with recent acquisitions and minority investments supporting growth and innovation.

Financial performance and growth outlook

• Achieved $738 million in revenue last year, with FY26 guidance set at $803M–$833M and 9–13% organic growth.

• Maintained 16% organic growth last year and 16% organic non-COVID growth in 2025, outpacing industry growth.

• Analytics and chromatography franchises projected to grow over 20% in FY26, with analytics up over 50% in Q1.

• Targeting mid-teens revenue CAGR through 2030, aiming to double the business primarily via organic growth.

• Committed to margin expansion, with a roadmap to ~30% EBITDA margin by 2030, driven by volume leverage, improved mix, and productivity.

Operational initiatives and efficiency

• Site rationalization underway, consolidating manufacturing to 8-10 core sites for efficiency and fit-for-growth initiatives.

• Service improvements reduced equipment installation time from four months to 1.5 weeks.

• Transformation Office also focuses on IT modernization, AI implementation, and operational excellence.

• Key account management leverages deep industry relationships to drive sales growth and cross-selling.

• Leadership structure strengthened to empower teams and support multi-billion dollar ambitions.